These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6136961)

  • 1. The experimental use of calcium antagonists in the treatment of arterial hypertension.
    Lederballe Pedersen O
    Postgrad Med J; 1983; 59 Suppl 2():84-90. PubMed ID: 6136961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid large artery remodeling following the administration and withdrawal of calcium channel blockers in spontaneously hypertensive rats.
    Vaja V; Ochodnicky P; Krenek P; Klimas J; Bajuszova Z; Kyselovic J
    Eur J Pharmacol; 2009 Oct; 619(1-3):85-91. PubMed ID: 19683522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Calcium antagonists in the treatment of chronic arterial hypertension and hypertensive crisis].
    Brandt D
    Wien Med Wochenschr; 1983 Mar; 133(6):131-5. PubMed ID: 6134398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and chronic captopril, but not prazosin or nifedipine, normalize alterations in adrenergic intracellular Ca2+ handling observed in the mesenteric arterial tree of spontaneously hypertensive rats.
    Miquel R; Gisbert R; Serna E; Perez-Vizcaino F; Anselmi E; Noguera MA; Ivorra MD; D'Ocon MP
    J Pharmacol Exp Ther; 2005 Apr; 313(1):359-67. PubMed ID: 15615866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of cardiovascular, renal, and humoral effects of acute administration of two calcium channel blockers in normotensive and hypertensive subjects.
    Leonetti G; Cuspidi C; Sampieri L; Terzoli L; Zanchetti A
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S319-24. PubMed ID: 6184561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and pharmacological properties of calcium antagonists in essential hypertension in humans and spontaneously hypertensive rats.
    Aoki K; Kawaguchi Y; Sato K; Kondo S; Yamamoto M
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S298-302. PubMed ID: 6184557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of sublingual verapamil in patients with severe essential hypertension: comparison with sublingual nifedipine.
    Al-Waili NS; Hasan NA
    Eur J Med Res; 1999 May; 4(5):193-8. PubMed ID: 10336409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nilvadipine: profile of a new calcium antagonist. An overview.
    Rosenthal J
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S92-107. PubMed ID: 7898101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium antagonists, firstline partners for betablockers in hypertension.
    Bühler FR
    Z Kardiol; 1984; 73 Suppl 2():95-9. PubMed ID: 6152093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of extracellular calcium in isometric contractions of the SHR aorta. Influence of age and antihypertensive treatment.
    Lederballe Pedersen O
    Arch Int Pharmacodyn Ther; 1979 Jun; 239(2):208-20. PubMed ID: 485725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
    Man in't Veld AJ; Schalekamp MA
    Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitrendipine and other calcium entry blockers (calcium antagonists) in hypertension.
    Kazda S; Garthoff B; Knorr A
    Fed Proc; 1983 Feb; 42(2):196-200. PubMed ID: 6822291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent vasoconstrictor actions of cyclopiazonic acid and thapsigargin on femoral arteries from spontaneously hypertensive rats.
    Nomura Y; Asano M; Ito K; Uyama Y; Imaizumi Y; Watanabe M
    Br J Pharmacol; 1997 Jan; 120(1):65-73. PubMed ID: 9117100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with verapamil reduces blood pressure and tends to normalize vascular responsiveness and ion transport in the spontaneously hypertensive rat.
    Lederballe Pedersen C; Mikkelsen E; Jespersen LT
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S294-7. PubMed ID: 6184556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nifedipine-sensitive noradrenergic vasoconstriction is enhanced in spontaneously hypertensive rats: the influence of chronic captopril treatment.
    Paulis L; Lísková S; Pintérová M; Dobesová Z; Kunes J; Zicha J
    Acta Physiol (Oxf); 2007 Dec; 191(4):255-66. PubMed ID: 17680837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Calcium antagonists in the treatment of arterial hypertension. Attempt at a differential therapy].
    Kiowski W
    Fortschr Med; 1984 Jul; 102(27-28):721-4. PubMed ID: 6479815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of calcium antagonists in the treatment of essential hypertension.
    Klein W; Brandt D; Vrecko K; Härringer M
    Circ Res; 1983 Feb; 52(2 Pt 2):I174-81. PubMed ID: 6831651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of calcium channel blockers in hypertension.
    Conlin PR; Williams GH
    Adv Intern Med; 1998; 43():533-62. PubMed ID: 9506192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Arterial hypertension: problems of maintenance therapy].
    Kozlovskiĭ IV
    Ter Arkh; 2006; 78(4):50-3. PubMed ID: 16821422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of morphological changes in spontaneously hypertensive rats and normotensive Wistar Kyoto rats treated with an angiotensin-converting enzyme inhibitor or a calcium-channel blocker.
    Saleh FH; Jurjus AR
    J Pathol; 2001 Mar; 193(3):415-20. PubMed ID: 11241424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.